Arch Venture Partners Xii, Llc

Affiliations

  • at Metsera Inc. (MTSR), 2025-02-04
  • at Rapport Therapeutics Inc. (RAPP), 2024-06-10
  • Large Shareholder at Prime Medicine Inc. (PRME), 2024-02-20
  • Large Shareholder at Neumora Therapeutics Inc. (NMRA), 2023-12-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MTSR $18.00 789,998 $14,219,964.00 8,313,680 2025-02-03 Filing
MTSR $18.00 1,432,224 $25,780,032.00 18,503,128 2025-02-03 Filing
PRME $6.25 3,200,000 $20,000,000.00 3,200,000 2024-02-15 Filing
NMRA $11.98 3,357 $40,216.86 4,131,207 2023-11-14 Filing
NMRA $11.75 31,653 $371,922.75 4,127,850 2023-11-13 Filing